EGOT and breast carcinoma: Purmorphamine restored the expression of Hh pathway genes and reversed the effects on cell viability and migration caused by overexpression of EGOT. EGOT thus may inhibit breast cancer cell viability and migration via inhibition of the Hh pathway.